Gadia, Viviano S.

HRN: 23-28-21  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2023
AZITHROMYCIN 500MG TABLET (TAB)
06/30/2023
07/04/2023
PO
500 Mg
OD
Tb
Waiting Final Action 
06/30/2023
CEFTRIAXONE 1G (VIAL)
06/30/2023
07/06/2023
IV
2 Grams
OD
Tb
Waiting Final Action 
07/01/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/01/2023
07/08/2023
IV
1.5gm
TID
Infected Wound
Waiting Final Action 
07/01/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/01/2023
07/08/2023
IV
600mg
QID
Infected Wound
Waiting Final Action 
07/03/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/03/2023
07/09/2023
IV
2.25g
Q6
Sepsis Multifactorial: CAP-HR, Sacral Ulcer
Waiting Final Action 
07/04/2023
FLUCONAZOLE 150MG (CAP)
07/04/2023
07/06/2023
PO
150mg
OD
Sepsis Secondary To Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: